Literature DB >> 26424648

Infectious Mononucleosis.

Samantha K Dunmire1, Kristin A Hogquist2, Henry H Balfour3.   

Abstract

Infectious mononucleosis is a clinical entity characterized by sore throat, cervical lymph node enlargement, fatigue, and fever most often seen in adolescents and young adults and lasting several weeks. It can be caused by a number of pathogens, but this chapter only discusses infectious mononucleosis due to primary Epstein-Barr virus (EBV) infection. EBV is a γ-herpesvirus that infects at least 90% of the population worldwide. The virus is spread by intimate oral contact among teenagers and young adults. How preadolescents acquire the virus is not known. A typical clinical picture with a positive heterophile test is usually sufficient to make the diagnosis, but heterophile antibodies are not specific and do not develop in some patients. EBV-specific antibody profiles are the best choice for staging EBV infection. In addition to causing acute illness, there can also be long-term consequences as the result of acquisition of the virus. Several EBV-related illnesses occur including certain cancers and autoimmune diseases, as well as complications of primary immunodeficiency in persons with the certain genetic mutations. A major obstacle to understanding these sequelae has been the lack of an efficient animal model for EBV infection, although progress in primate and mouse models has recently been made. Key future challenges are to develop protective vaccines and effective treatment regimens.

Entities:  

Mesh:

Year:  2015        PMID: 26424648      PMCID: PMC4670567          DOI: 10.1007/978-3-319-22822-8_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  131 in total

Review 1.  Acute complications of Epstein-Barr virus infectious mononucleosis.

Authors:  H B Jenson
Journal:  Curr Opin Pediatr       Date:  2000-06       Impact factor: 2.856

2.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Risk of Hodgkin's disease and other cancers after infectious mononucleosis.

Authors:  H Hjalgrim; J Askling; P Sørensen; M Madsen; N Rosdahl; H H Storm; S Hamilton-Dutoit; L S Eriksen; M Frisch; A Ekbom; M Melbye
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

Review 4.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

5.  The changing epidemiology of infectious mononucleosis?

Authors:  M C Morris; W J Edmunds
Journal:  J Infect       Date:  2002-08       Impact factor: 6.072

6.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

Review 7.  Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology.

Authors:  G Bauer
Journal:  Clin Lab       Date:  2001       Impact factor: 1.138

Review 8.  Epstein-Barr virus in the pathogenesis of NPC.

Authors:  Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2002-12       Impact factor: 15.707

9.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

10.  The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.

Authors:  N Blake; T Haigh; G Shaka'a; D Croom-Carter; A Rickinson
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

View more
  55 in total

1.  Hypertrophic chronic pachymeningitis associated with Epstein-Barr virus reactivation: a case report.

Authors:  Raffaele Nardone; Francesco Brigo; Markus Covi; Luca Carnicelli; Francesca Caleri; Hannes Tischler; Larissa Hauer; Johann Sellner
Journal:  J Neurovirol       Date:  2019-02-11       Impact factor: 2.643

Review 2.  Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime.

Authors:  Kaitlin E Johnson; Vera L Tarakanova
Journal:  Viral Immunol       Date:  2020-01-08       Impact factor: 2.257

3.  Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease.

Authors:  Rizwan S Akhtar; Joseph P Licata; Kelvin C Luk; Leslie M Shaw; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurochem       Date:  2018-06-10       Impact factor: 5.372

4.  False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.

Authors:  Marika Valota; Friedrich Thienemann; Benjamin Misselwitz
Journal:  BMJ Case Rep       Date:  2019-05-10

5.  Early Disseminated Lyme Disease Causing False-Positive Serology for Primary Epstein-Barr Virus Infection: Report of 2 Cases.

Authors:  Adriana J Pavletic; Adriana R Marques
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

6.  Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China: A nationwide retrospective study.

Authors:  Mengjia Liu; Xinyu Wang; Linlin Zhang; Guoshuang Feng; Yueping Zeng; Ran Wang; Zhengde Xie
Journal:  Virol Sin       Date:  2022-07-12       Impact factor: 6.947

Review 7.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

8.  A three year Seroepidemiological and molecular study of Epstein -Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India ( 2017 -2019).

Authors:  Sangram Singh Patel; Sweta Singh; Chinmoy Sahu; Ujjala Ghoshal; Hemant Verma
Journal:  J Family Med Prim Care       Date:  2021-01-30

9.  Infectious Mononucleosis: A Case Report With Unusual Features and Abnormal Laboratory Findings.

Authors:  Ammar Alli; Farah Nabil; Juan Fernando Ortiz
Journal:  Cureus       Date:  2021-05-01

10.  Febrile palpebral edema.

Authors:  Mohammad Yassine Chérif; Bertrand Richert
Journal:  JAAD Case Rep       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.